First FDA-approved cellular therapy for metastatic melanoma available in South Florida

FHS
May 2, 2024
4:04 am

Patients in South Florida with metastatic melanoma will soon have access to the first cellular therapy for this advanced form of skin cancer, following its recent approval by the Food and Drug Administration (FDA).

INTEGRA Biosciences’ pipettes help to cultivate success in agriculture

The National Agricultural Research and Development Institute (NARDI) in Fundulea, Romania, relies on electronic multichannel pipettes from INTEGRA Biosciences to streamline its liquid handling workflows.

July 9, 2024

Bayer makes $250m investment in Berkeley cell therapy plant

Spread over 100,000ft², the newly opened facility will aid in manufacturing material needed for clinical trials. Credit: Bayer/Business Wire. Bayer has made an investment of

October 10, 2023

Risk adjusted net present value: What is the current valuation of Forte Biosciences’s FB-102?

FB-102 is a monoclonal antibody commercialized by Forte Biosciences, with a leading Phase I program in Celiac Disease.

December 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.